Welcome to our dedicated page for Healthpeak Properties news (Ticker: DOC), a resource for investors and traders seeking the latest updates and insights on Healthpeak Properties stock.
Healthpeak Properties, Inc. (NYSE: DOC) is a fully integrated healthcare-focused REIT and S&P 500 company, and its news flow reflects its role as an owner, operator, and developer of real estate for healthcare discovery and delivery. This page aggregates company news so readers can follow announcements about its medical office, life science, and senior housing platforms.
Healthpeak’s news includes updates on capital allocation and transactions, such as acquisitions of life science campuses and dispositions of fully stabilized outpatient medical buildings. For example, the company has reported approximately $925 million of transaction activity, including the acquisition of a 1.4-million square foot campus on Gateway Boulevard in South San Francisco and outpatient medical dispositions totaling hundreds of millions of dollars. News items also cover negotiations and execution on additional outpatient medical sales, recapitalizations, and loan repayments.
Investors can also find earnings-related news, including announcements of quarterly financial results, guidance ranges for key non-GAAP metrics, and conference call details. The company regularly issues press releases with dates and access information for earnings calls and webcasts, as well as links to supplemental reports and reconciliations of non-GAAP financial measures.
Healthpeak’s news flow further covers strategic initiatives such as the planned IPO of Janus Living, Inc., a senior housing REIT that will own Healthpeak’s 34-community, 10,422-unit senior housing portfolio, with Healthpeak serving as external manager. Additional releases highlight monthly dividend declarations, updates to investor presentations, and the publication of the company’s Corporate Impact Report, which describes its sustainability and governance efforts.
By reviewing this news feed, readers can track Healthpeak’s portfolio strategy, transaction activity, dividend announcements, and key corporate developments over time.
Healthpeak Properties (NYSE: DOC) announced it confidentially submitted a draft Form S-11 to the SEC for the proposed IPO of Janus Living, Inc., a newly formed REIT vehicle holding senior housing assets under a RIDEA structure.
The IPO is expected to comprise Healthpeak’s 34 senior housing assets; proceeds are expected to be used for pending acquisitions, debt repayment, and general corporate purposes. Healthpeak said it intends to maintain control of Janus Living after the offering and expects to complete the IPO in the first half of 2026, subject to market conditions, regulatory approvals, related financings, SEC review, and customary conditions.
Healthpeak Properties (NYSE:DOC) announced that on Jan 4, 2026 its board declared a monthly common stock cash dividend of $0.10167 per share for the first quarter of 2026. The dividend equates to an annualized amount of $1.22 per share. Payment and record dates are scheduled as follows: record dates of Jan 16, Feb 13, Mar 17, 2026 with corresponding payment dates of Jan 30, Feb 27, Mar 31, 2026. The dividends are payable to stockholders of record as of each listed record date.
Healthpeak Properties (NYSE:DOC) published an updated investor presentation on December 8, 2025 ahead of upcoming investor meetings. The presentation covers the company’s strategy and recent developments and is available on Healthpeak’s investor relations website at https://ir.healthpeak.com.
Healthpeak Properties (NYSE: DOC) reported third-quarter 2025 results and a strategic update on October 23, 2025. Key operating highlights include Outpatient Medical cash releasing spreads of +5.4%, third-quarter Merger-Combined Same-Store NOI up 0.9%, and CCRC NOI +9.4% in Q3 (YTD +11.3%). The company executed 1.5 million square feet of leases in Q3 and has signed LOIs for additional outpatient and lab space through October 23, 2025. Balance sheet items: $2.7 billion available liquidity and Net Debt / Adjusted EBITDAre 5.3x. Management reaffirmed most 2025 guidance but narrowed earnings per share to $0.00–$0.06 (updated from $0.25–$0.31).
Healthpeak Properties (NYSE:DOC) announced that its Board declared a monthly common stock cash dividend of $0.10167 per share for each month of the fourth quarter of 2025. The dividend equals an annualized amount of $1.22 per share.
The declaration sets three record/payment date pairs: record dates of Oct 17, Nov 14, Dec 19, 2025 with corresponding payment dates of Oct 30, Nov 26, Dec 30, 2025, each paying $0.10167 per common share.
Healthpeak Properties (NYSE: DOC), a healthcare real estate company, has scheduled its Q3 2025 earnings release for Thursday, October 23, 2025, after market close. The company will host a conference call and webcast on Friday, October 24, 2025, at 10:00 a.m. Eastern Time to discuss financial results.
Investors can access the conference call through Healthpeak's website or via telephone at (800) 715-9871. A webcast replay will be available on the company's website through October 23, 2026, and a telephonic replay can be accessed through October 31, 2025.
Healthpeak Properties (NYSE: DOC) has released its 14th annual Corporate Impact Report for 2024, showcasing significant achievements in sustainability and corporate governance following its March 2024 merger with Physicians Realty Trust. The company has exceeded two 10-year sustainability targets ahead of schedule, achieving an 11.5% reduction in water consumption and 12.1% increase in recycling since 2020.
Key environmental achievements include an 8.2% reduction in greenhouse gas emissions and 1.8% reduction in energy use in 2024. The company secured 590,000 square feet of new LEED certifications and was named a 2024 ENERGY STAR Partner of the Year for Sustained Excellence. Healthpeak also launched the IDEA Council to enhance workplace culture and strengthened its governance practices.
Healthpeak Properties (NYSE:DOC) has announced key leadership changes to strengthen its life science real estate division. Denis Sullivan joins as Managing Director of Lab Investments & San Diego Market Lead, bringing over two decades of life science real estate expertise, including 14 years at BioMed Realty as CIO and CFO. Additionally, Mike Dorris has been promoted to Head of West Coast Development & Construction.
Sullivan will report to Adam Mabry (CIO) and Scott Bohn (CDO), focusing on portfolio-wide Lab investment strategy and San Diego market operations. Dorris will expand the company's specialized lab design and construction capabilities while strengthening development initiatives. These strategic appointments aim to capitalize on market recovery opportunities and enhance Healthpeak's position in the life science sector.
Healthpeak Properties (NYSE: DOC), through its operating company Healthpeak OP, LLC, has priced a $500 million offering of senior unsecured notes due 2033 with a 4.750% interest rate. The notes are priced at 99.178% of principal amount, with estimated net proceeds of $492.8 million after underwriting discount.
The notes will be fully guaranteed by Healthpeak, DOC DR Holdco, LLC and DOC DR, LLC. The company plans to use the proceeds to repay commercial paper borrowings and for general corporate purposes, including potential debt repayment, acquisitions, development activities, and capital expenditures. The offering is expected to close on August 14, 2025.
Healthpeak Properties (NYSE:DOC) reported its Q2 2025 financial results with net income of $0.05 per share, Nareit FFO of $0.43 per share, and FFO as Adjusted of $0.46 per share. The company demonstrated strong operational performance with Total Merger-Combined Same-Store Cash NOI growth of 3.5%.
Key highlights include 1.5 million square feet of new and renewal lease executions, with strong retention rates of 85% for outpatient medical and 87% for lab spaces. The company entered into two new development agreements worth $148 million with Northside Hospital in Atlanta and declared a quarterly dividend of $0.305 per share.
Healthpeak maintained solid financial health with Net Debt to Adjusted EBITDAre of 5.2x and approximately $2.3 billion in available liquidity. The company reaffirmed its 2025 FFO as Adjusted guidance of $1.81-$1.87 per share while updating its diluted earnings guidance to $0.25-$0.31 per share.